comparemela.com
Home
Live Updates
Company Collaborations Licensing Partnering Analysis - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Company collaborations licensing partnering analysis - Page 1 : comparemela.com
World Diphtheria Pipeline Research Report 2024: Commercial
Dublin, April 19, 2024 (GLOBE NEWSWIRE) The
Dublin
Ireland
Route-of-administration
University-collaborations-licensing-partnering-analysis
Diphtheria-key-companies
Phase-of-development
Company-collaborations-licensing-partnering-analysis
Product-development-activities
Pipeline-insight
Diphtheria-commercial-assessment
Clinical-assessment
Global Dental Pain Pipeline Developments Report 2024
Dublin, April 18, 2024 (GLOBE NEWSWIRE) The
Dublin
Ireland
Route-of-administration
Product-development-activities
Pain-key-companies
University-collaborations-licensing-partnering-analysis
Phase-of-development
Pipeline-development-activities
Company-collaborations-licensing-partnering-analysis
Dental-pain
Clinical-assessments-catalyze-market
Opioid-Induced Constipation Pipeline Insight 2024
Dublin, April 18, 2024 (GLOBE NEWSWIRE) The
Dublin
Ireland
Route-of-administration
Constipation-key-companies
Product-development-activities
Phase-of-development
Company-collaborations-licensing-partnering-analysis
University-collaborations-licensing-partnering-analysis
Induced-constipation
Opioid-induced-constipation
Opioid-induced-constipation-commercial-assessment
World Metastatic Prostate Cancer Drug Landscape Research
Dublin, April 18, 2024 (GLOBE NEWSWIRE) The
Kangpu
Yunnan
China
Japan
Dublin
Ireland
Chinese
Eli-lilly
Leuprolide-mesylate
Orion-pharma
Roche-ipatasertib
Myovant-biosciences-relugolix
Pollen Allergy Pipeline Insight Report 2024: Clinical
Dublin, April 12, 2024 (GLOBE NEWSWIRE) The
Dublin
Ireland
Phase-of-development
Route-of-administration
Company-collaborations-licensing-partnering-analysis
University-collaborations-licensing-partnering-analysis
Pollen-allergy-key-companies
Pollen-allergy
Pollen-allergy-commercial-assessment
Allergy-clinical-assessment
Topics-covered
vimarsana © 2020. All Rights Reserved.